Molecular and Biochemical Characterization of a Cathepsin B-Like Protease Family Unique toTrypanosoma congolense
- 1 April 2008
- journal article
- Published by American Society for Microbiology in Eukaryotic Cell
- Vol. 7 (4), 684-697
- https://doi.org/10.1128/ec.00405-07
Abstract
Cysteine proteases have been shown to be essential virulence factors and drug targets in trypanosomatids and an attractive antidisease vaccine candidate forTrypanosoma congolense. Here, we describe an important amplification of genes encoding cathepsin B-like proteases unique toT. congolense. More than 13 different genes were identified, whereas only one or two highly homologous genes have been identified in other trypanosomatids. These proteases grouped into three evolutionary clusters: TcoCBc1 to TcoCBc5 and TcoCBc6, which possess the classical catalytic triad (Cys, His, and Asn), and TcoCBs7 to TcoCBs13, which contains an unusual catalytic site (Ser, Xaa, and Asn). Expression profiles showed that members of the TcoCBc1 to TcoCBc5 and the TcoCBs7 to TcoCBs13 groups are expressed mainly in bloodstream forms and localize in the lysosomal compartment. The expression of recombinant representatives of each group (TcoCB1, TcoCB6, and TcoCB12) as proenzymes showed that TcoCBc1 and TcoCBc6 are able to autocatalyze their maturation 21 and 31 residues, respectively, upstream of the predicted start of the catalytic domain. Both displayed a carboxydipeptidase function, while only TcoCBc1 behaved as an endopeptidase. TcoCBc1 exhibited biochemical differences regarding inhibitor sensitivity compared to that of other cathepsin B-like proteases. Recombinant pro-TcoCBs12 did not automature in vitro, and the pepsin-matured enzyme was inactive in tests with cathepsin B fluorogenic substrates. In vivo inhibition studies using CA074Me (a cell-permeable cathepsin B-specific inhibitor) demonstrated that TcoCB are involved in lysosomal protein degradation essential for survival in bloodstream form. Furthermore, TcoCBc1 elicited an important immune response in experimentally infected cattle. We propose this family of proteins as a potential therapeutic target and as a plausible antigen forT. congolensediagnosis.Keywords
This publication has 77 references indexed in Scilit:
- Evidence for a Common Role for the Serine-Type Plasmodium falciparum Serine Repeat Antigen Proteases: Implications for Vaccine and Drug DesignInfection and Immunity, 2007
- Immune system recognition of Trypanosoma cruziCurrent Opinion in Immunology, 2007
- Schistosomiasis Mansoni: Novel Chemotherapy Using a Cysteine Protease InhibitorPLoS Medicine, 2007
- Improved Prediction of Signal Peptides: SignalP 3.0Journal of Molecular Biology, 2004
- Carboxydipeptidase activities of recombinant cysteine peptidasesJBIC Journal of Biological Inorganic Chemistry, 2004
- Enzymic, Phylogenetic, and Structural Characterization of the Unusual Papain-like Protease Domain of Plasmodium falciparum SERA5Published by Elsevier BV ,2003
- Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteineJournal of Molecular Biology, 2000
- N-peptidyl, O-acyl hydroxamates: comparison of the selective inhibition of serine and cysteine proteinasesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1996
- Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivoFEBS Letters, 1991
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970